Harish Rao

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

Mehreen S. Datoo, Alassane Dicko, Halidou Tinto et al. · The Lancet · 2024 · 351 citations · Full text

Veterinary Medicine, Child Health, Pediatrics +17

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Hitt Sharma, Sameer Parekh, Pramod Pujari et al. · The Lancet Oncology · 2023 · 41 citations

Veterinary Medicine, Immunology, Pediatrics +11

SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques

Neil C. Dalvie, Lisa H. Tostanoski, Sergio A. Rodriguez‐Aponte et al. · Science Advances · 2022 · 37 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered <i>Komagataella phaffii</i>

Neil C. Dalvie, Andrew M. Biedermann, Sergio A. Rodriguez‐Aponte et al. · Biotechnology and Bioengineering · 2021 · 35 citations · Full text

Pharmacy, Bioengineering, Biotechnology +17

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge

Ting Y. Wong, Brynnan P. Russ, Katherine S. Lee et al. · mSphere · 2022 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17